Table 2.
Whole study cohort as well as subgroup volumetric and growth rate results.
| Volumes (cc) | Absolute Growth Rate (AGR; cc/yr) | |||||
|---|---|---|---|---|---|---|
| Baseline | Last on Tx | Best Response | Before treatment | First year | Entire duration | |
| Mean | 29.5 | 25.3 | 23.8 | 8.0 | −0.2 | −1.2 |
| ±SD | 32.1 | 22.0 | 22.5 | 7.7 | 7.9 | 10.6 |
| p-value | — | ns | 0.09 | — | 0.05 | 0.05 |
| Mean | 36.4 | 28.5 | 27.6 | 7.9 | −1.9 | −5.6 |
| ±SD | 37.2 | 24.8 | 25.6 | 8.4 | 8.3 | 7.4 |
| p-value | — | ns | 0.07 | — | 0.09 | 0.04 |
| Mean | 15.8 | 18.8 | 16.2 | 8.0 | 3.2 | 7.5 |
| ±SD | 13.3 | 16.1 | 14.2 | 7.3 | 6.9 | 11.5 |
| p-value | — | ns | ns | — | ns | ns |
| Mean | 7.4 | 10.2 | 8.0 | 2.1 | 3.2 | 2.1 |
| ±SD | 5.1 | 6.5 | 5.1 | 1.6 | 4.9 | 5.0 |
| p-value | — | ns | ns | — | ns | ns |
| Mean | 51.7 | 40.4 | 39.7 | 13.8 | −3.7 | −4.5 |
| ±SD | 32.7 | 21.9 | 21.9 | 6.9 | 9.3 | 14.1 |
| p-value | — | ns | 0.07 | — | 0.01 | 0.03 |
Large tumor defined as ≥14 cc at baseline based on the studied populations median.